Free Trial
NASDAQ:MOVE

Movano Q4 2024 Earnings Report

Movano logo
$0.62 +0.03 (+5.08%)
Closing price 04:00 PM Eastern
Extended Trading
$0.61 -0.01 (-2.10%)
As of 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Movano EPS Results

Actual EPS
-$0.61
Consensus EPS
-$0.97
Beat/Miss
Beat by +$0.36
One Year Ago EPS
N/A

Movano Revenue Results

Actual Revenue
$0.11 million
Expected Revenue
$1.50 million
Beat/Miss
Missed by -$1.39 million
YoY Revenue Growth
N/A

Movano Announcement Details

Quarter
Q4 2024
Time
Before Market Opens
Conference Call Date
Wednesday, April 9, 2025
Conference Call Time
4:00PM ET

Upcoming Earnings

Movano's Q1 2025 earnings is scheduled for Wednesday, August 13, 2025

Earnings Documents

Movano Earnings Headlines

Your Bank Account Is No Longer Safe
What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.
Gold Moves Lower; Lucid Group Shares Jump
See More Movano Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Movano? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Movano and other key companies, straight to your email.

About Movano

Movano (NASDAQ:MOVE), headquartered in San Jose, California, develops advanced wearable devices designed to monitor and analyze key health metrics in real time. The company focuses on providing continuous biometric insights that address both general wellness and specific medical applications. Movano’s technology platform integrates sensor hardware, proprietary algorithms and a cloud-based analytics engine to deliver actionable data to end users and healthcare providers.

Movano’s flagship device, the Maven smart ring, uses a suite of miniaturized sensors to track vital signs such as heart rate, skin temperature, respiration and blood oxygen levels throughout the day and night. Complementary to the ring is a discrete adhesive patch that can support extended monitoring of parameters like glucose trends and stress biomarkers. Data from these devices feed into a secure mobile application, allowing users to view personalized health reports and receive tailored recommendations based on longitudinal trends.

Since its founding in 2021, Movano has expanded its operations beyond the U.S. market, establishing partnerships with research institutions and healthcare organizations in Europe and Asia. The company collaborates with clinical investigators to validate its devices in studies of metabolic health, women’s hormonal cycles and chronic disease management. Movano also works with corporate wellness programs and telehealth providers to integrate its wearable data into broader preventive care and patient engagement initiatives.

Movano’s leadership team combines expertise in biomedical engineering, consumer electronics and digital health. The company is led by CEO Terry McBride, a technology entrepreneur with a track record of scaling consumer-focused ventures, and is supported by a management group with deep experience in regulatory affairs, product development and clinical research. Under this guidance, Movano seeks to advance wearable diagnostics and expand its platform into new areas of precision health.

View Movano Profile

More Earnings Resources from MarketBeat